Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 157

1.

Depression and Disturbed Bone Metabolism: A Narrative Review of the Epidemiological Findings and Postulated Mechanisms.

Rosenblat JD, Gregory JM, Carvalho AF, McIntyre RS.

Curr Mol Med. 2016;16(2):165-78.

PMID:
26812918
2.

Protective effects of exercise in metabolic disorders are mediated by inhibition of mitochondrial-derived sterile inflammation.

Peeri M, Amiri S.

Med Hypotheses. 2015 Dec;85(6):707-9. doi: 10.1016/j.mehy.2015.10.026. Epub 2015 Oct 26.

PMID:
26527493
3.

Animal Models for the Study of Comorbid Pain and Psychiatric Disorders.

Leite-Almeida H, Pinto-Ribeiro F, Almeida A.

Mod Trends Pharmacopsychiatri. 2015;30:1-21. doi: 10.1159/000435929. Epub 2015 Sep 18. Review.

PMID:
26436914
4.

Ribosomal protein S6 kinase 1 signaling in prefrontal cortex controls depressive behavior.

Dwyer JM, Maldonado-Avilés JG, Lepack AE, DiLeone RJ, Duman RS.

Proc Natl Acad Sci U S A. 2015 May 12;112(19):6188-93. doi: 10.1073/pnas.1505289112. Epub 2015 Apr 27.

5.

Melancholic-Like behaviors and circadian neurobiological abnormalities in melatonin MT1 receptor knockout mice.

Comai S, Ochoa-Sanchez R, Dominguez-Lopez S, Bambico FR, Gobbi G.

Int J Neuropsychopharmacol. 2015 Jan 31;18(3). pii: pyu075. doi: 10.1093/ijnp/pyu075.

6.

Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.

Franceschelli A, Sens J, Herchick S, Thelen C, Pitychoutis PM.

Neuroscience. 2015 Apr 2;290:49-60. doi: 10.1016/j.neuroscience.2015.01.008. Epub 2015 Jan 14.

PMID:
25595985
7.

[The contributing risk factors, prevention and treatment of functional dependence among the oldest-old and elderly subjects].

Liu D, Tan J, Guo Y, Ye G, Zhu L, Zhang J, Li Y, Deng Y, Wang G, Wang L.

Zhonghua Nei Ke Za Zhi. 2014 Oct;53(10):772-7. Chinese.

PMID:
25567147
8.

Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress.

Luo YW, Xu Y, Cao WY, Zhong XL, Duan J, Wang XQ, Hu ZL, Li F, Zhang JY, Zhou M, Dai RP, Li CQ.

Neuropharmacology. 2015 Feb;89:318-24.

PMID:
25446675
9.

Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone.

Cheng Y, Rodriguiz RM, Murthy SR, Senatorov V, Thouennon E, Cawley NX, Aryal DK, Ahn S, Lecka-Czernik B, Wetsel WC, Loh YP.

Mol Psychiatry. 2015 Jun;20(6):744-54. doi: 10.1038/mp.2014.136. Epub 2014 Oct 21.

10.

Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters.

Aboul-Fotouh S.

Psychopharmacology (Berl). 2015 Mar;232(6):1095-105. doi: 10.1007/s00213-014-3745-5. Epub 2014 Oct 15.

PMID:
25315361
11.

Long-term corticosterone exposure decreases insulin sensitivity and induces depressive-like behaviour in the C57BL/6NCrl mouse.

van Donkelaar EL, Vaessen KR, Pawluski JL, Sierksma AS, Blokland A, Cañete R, Steinbusch HW.

PLoS One. 2014 Oct 13;9(10):e106960. doi: 10.1371/journal.pone.0106960. eCollection 2014.

12.

Sodium butyrate functions as an antidepressant and improves cognition with enhanced neurotrophic expression in models of maternal deprivation and chronic mild stress.

Valvassori SS, Varela RB, Arent CO, Dal-Pont GC, Bobsin TS, Budni J, Reus GZ, Quevedo J.

Curr Neurovasc Res. 2014;11(4):359-66.

PMID:
25233278
13.

Effect of acute swim stress on plasma corticosterone and brain monoamine levels in bidirectionally selected DxH recombinant inbred mouse strains differing in fear recall and extinction.

Browne CA, Hanke J, Rose C, Walsh I, Foley T, Clarke G, Schwegler H, Cryan JF, Yilmazer-Hanke D.

Stress. 2014 Dec;17(6):471-83. doi: 10.3109/10253890.2014.954104.

14.
15.

Pramipexole but not imipramine or fluoxetine reverses the "depressive-like" behaviour in a rat model of preclinical stages of Parkinson's disease.

Berghauzen-Maciejewska K, Kuter K, Kolasiewicz W, Głowacka U, Dziubina A, Ossowska K, Wardas J.

Behav Brain Res. 2014 Sep 1;271:343-53. doi: 10.1016/j.bbr.2014.06.029. Epub 2014 Jun 20.

PMID:
24956561
16.

Pycnogenol ameliorates depression-like behavior in repeated corticosterone-induced depression mice model.

Mei L, Mochizuki M, Hasegawa N.

Biomed Res Int. 2014;2014:942927. doi: 10.1155/2014/942927. Epub 2014 May 13.

17.

Physical inactivity is strongly associated with anxiety and depression in Iraqi immigrants to Sweden: a cross-sectional study.

Siddiqui F, Lindblad U, Bennet L.

BMC Public Health. 2014 May 25;14:502. doi: 10.1186/1471-2458-14-502.

18.

Demyelinating evidences in CMS rat model of depression: a DTI study at 7 T.

Hemanth Kumar BS, Mishra SK, Trivedi R, Singh S, Rana P, Khushu S.

Neuroscience. 2014 Sep 5;275:12-21. doi: 10.1016/j.neuroscience.2014.05.037. Epub 2014 May 29.

PMID:
24881571
19.

Comparison of depressive behaviors induced by three stress paradigms in rats.

Bai M, Zhang L, Zhu X, Zhang Y, Zhang S, Xue L.

Physiol Behav. 2014 May 28;131:81-6. doi: 10.1016/j.physbeh.2014.04.019. Epub 2014 Apr 18.

PMID:
24747276
20.

Acid-induced hyperalgesia and anxio-depressive comorbidity in rats.

Liu YT, Shao YW, Yen CT, Shaw FZ.

Physiol Behav. 2014 May 28;131:105-10. doi: 10.1016/j.physbeh.2014.03.030. Epub 2014 Apr 12.

PMID:
24726391
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk